The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
Abstract
Purpose: Speed of blast clearance is an indicator of outcome in childhood acute lymphoblastic leukemia (ALL). Availability of measurement of minimal residual disease (MRD) at an early time point with a reduced-cost method is of clinical relevance. In the AIEOP-BFM-ALL (Associazione Italiana Ematologia Oncologia Pediatrica and Berlin-Frankfurt-Münster Study Group) 2000 trial, patients were stratified by levels of polymerase chain reaction (PCR) MRD at day +33 and +78. AIEOP studied the prognostic impact of MRD measured by flow cytometry (FCM) at day 15 of induction therapy. Patients and Methods: Bone marrow samples from 830 Italian patients were collected on day 15, after 14 days of steroids, and one dose of intrathecal methotrexate, vincristine, daunorubicine, and asparaginase. Cells were analyzed by four-color FCM for detection of leukemia-associated immunophenotypes. Results: Three patient risk groups were identified by FCM: standard (< 0.1% blast cells; 42% of the total), intermediate (0.1 to < 10%; 47%), and high (≥ 10%; 11%). Their 5-year cumulative incidences of relapse were 7.5% (SE, 1.5), 17.5% (SE, 2.1), and 47.2% (SE, 5.9), respectively. In multivariate analysis, FCM was the most important prognostic factor among those available by day 15, with two-fold and five-fold increase in the risk of relapse compared with patients with less than 0.1%. PCR MRD, when added to the model, had significant prognostic impact; yet high levels of FCM MRD retained an independent ability to detect a significantly higher risk of relapse. Conclusion: Measurement of FCM MRD in day 15 bone marrow was the most powerful early predictor of relapse, applicable to virtually all patients; it may complement PCR MRD–based stratification including later time points, thus allowing additional treatment tailoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
van Dongen, J. J., Seriu, T., Panzer-Grümayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04058-6 · Cited by 952
Self-citationBorowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S., Martin, P. L., Pullen, D. J., Viswanatha, D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 842
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Cavé, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B., Vilmer, E., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390904 · Cited by 768
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Sancho, J., Hancock, M. L., Boyett, J. M., Behm, F. G., Raimondi, S. C., Sandlund, J. T., Rivera, G. K., Rubnitz, J. E., Ribeiro, R. C., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2691 · Cited by 484
Schultz, K. R., Pullen, D. J., Sather, H. N., Shuster, J. J., Devidas, M., Borowitz, M. J., Carroll, A. J., Heerema, N. A., Rubnitz, J. E., Loh, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-01-024729 · Cited by 475
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
Coustan-Smith, E., Behm, F. G., Sanchez, J., Boyett, J. M., Hancock, M. L., Raimondi, S. C., Rubnitz, J. E., Rivera, G. K., Sandlund, J. T., Pui, C.-H., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10295-1 · Cited by 447
Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grümayer, R., van der Velden, V, Fischer, S., Stanulla, M., Basso, G., Niggli, F. K., Schäfer, B. W., et al. (2008) · Leukemia · doi:10.1038/leu.2008.5 · Cited by 361
Self-citationDworzak, M. N., Fröschl, G., Printz, D., Mann, G., Pötschger, U., Mühlegger, N., Fritsch, G., & Gadner, H. (2002) · Blood · doi:10.1182/blood.v99.6.1952 · Cited by 325
Self-citationCoustan-Smith, E., Sancho, J., Behm, F. G., Hancock, M. L., Razzouk, B. I., Ribeiro, R. C., Rivera, G. K., Rubnitz, J. E., Sandlund, J. T., Pui, C.-H., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0006 · Cited by 272
Brisco, M. J., Condon, J., Hughes, E., Neoh, S. H., Sykes, P. J., Seshadri, R., Morley, A. A., Toogood, I. R. G., Waters, K. A., Tauro, G. P., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90988-1 · Cited by 266
Riehm, H., Reiter, A., Schrappe, M., Berthold, F., Dopfer, R., Gerein, V., Ludwig, R., Ritter, J., Stollmann, B., & Henze, G. (1987) · Klinische Pädiatrie · doi:10.1055/s-2008-1026781 · Cited by 260
Dworzak, M. N., Gaipa, G., Ratei, R., et al. (2008) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20430 · Cited by 157
Self-citationvan der Velden, V. H. J., Panzer‐Grümayer, E. R., Cazzaniga, G., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404535 · Cited by 151
Coustan‐Smith, E., Ribeiro, R. C., Stow, P., Zhou, Y., Pui, C., Rivera, G. K., Pedrosa, F. D. P. R., & Campana, D. (2006) · Blood · doi:10.1182/blood-2006-01-0066 · Cited by 133
Fellows, E., Gil-Parrado, S., Jenne, D. E., & Kurschus, F. C. (2007) · Blood · doi:10.1182/blood-2006-10-051649 · Cited by 122
Malec, M., Björklund, E., Söderhäll, S., Mazur, J., Sjögren, A.-M., Pisa, P., Björkholm, M., & Porwit‐MacDonald, A. (2001) · Leukemia · doi:10.1038/sj.leu.2402091 · Cited by 44
Cited by
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Conter, V., Bartram, C. R., Valsecchi, M. G., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Aricò, M., Zimmermann, M., Mann, G., De Rossi, G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-248146 · Cited by 785
Self-citationvan Dongen, J. J. M., van der Velden, V. H. J., Brüggemann, M., & Orfao, A. (2015) · Blood · doi:10.1182/blood-2015-03-580027 · Cited by 511
Automated identification of stratifying signatures in cellular subpopulations
Bruggner, R. V., Bodenmiller, B., Dill, D. L., Tibshirani, R. J., & Nolan, G. P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408792111 · Cited by 473
Metadata
- Authors
- Basso, G., Veltroni, M., Valsecchi, M. G., Dworzak, M. N., Ratei, R., Silvestri, D., Benetello, A., Buldini, B., Maglia, O., Masera, G., Conter, V., Arico, M., Biondi, A., & Gaipa, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-11-01
- Volume
- 27
- Issue
- 31
- Pages
- 5168-5174
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105608321
- Cited by
- 284
- References
- 17
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.